Korean Red Ginseng slows coreceptor switch in HIV-1 infected patients
Authors:
Open Access
- 6 July 2022
- journal article
- research article
- Published by Elsevier in Journal of Ginseng Research
- Vol. 47 (1) , 117-122
Abstract
No abstract availableKeywords
Funding Information
- Korean Society of Ginseng
This publication has 35 references indexed in Scilit:
- Frequent Genetic Defects in the HIV-1 5'LTR/gag Gene in Hemophiliacs Treated with Korean Red Ginseng: Decreased Detection of Genetic Defects by Highly Active Antiretroviral TherapyJournal of Ginseng Research, 2011
- Phylogenetic Analysis of Full-Length pol Gene from Korean Hemophiliacs and Plasma Donors Infected with Korean Subclade B of HIV Type 1AIDS Research and Human Retroviruses, 2011
- Ginsenoside Re enhances survival of human CD4+ T cells through regulation of autophagyInternational Immunopharmacology, 2010
- Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infectionInfection, Genetics and Evolution, 2010
- Frequent Gross Deletion in the HIV Type 1 nef Gene in Hemophiliacs Treated with Korean Red Ginseng: Inhibition of Detection by Highly Active Antiretroviral TherapyAIDS Research and Human Retroviruses, 2009
- High Frequency of Gross Deletions in the 5′ LTR and gag Regions in HIV Type 1-Infected Long-Term Survivors Treated with Korean Red GinsengAIDS Research and Human Retroviruses, 2008
- Molecular epidemiologic study of a human immunodeficiency virus 1 outbreak in haemophiliacs B infected through clotting factor 9 after 1990Vox Sanguinis, 2006
- The HIV coreceptor switch: a population dynamical perspectiveTrends in Microbiology, 2005
- Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequencesJournal of Virology, 2003
- Performance of the OraQuick Rapid Antibody Test for Diagnosis of Human Immunodeficiency Virus Type 1 Infection in Patients with Various Levels of Exposure to Highly Active Antiretroviral TherapyJournal of Clinical Microbiology, 2003